The contraceptive choice for a Wilson's disease patient with chronic liver disease

Ronit Haimov-Kochman, Zvi Ackerman, Eyal Y. Anteby

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Preserved fertility stains is frequently encountered in patients with Wilson's disease, and contraceptive counseling may, therefore, be a relevant tissue. Yet, several contraceptive methods can adversely influence the hepatic function, and the efficacy of others may be affected by the liver disease. We describe a patient with Wilson's disease manifested by cirrhosis, portal hypertension, and bleeding esophageal varices who underwent termination of pregnancy at 9 weeks' gestation. Following the procedure, contraceptive advice was sough in order to postpone conception until portal hypertension was controlled and hepatic function improved. Intramuscular depto medroxyprogesterone acetate was administered and tolerated well by the patient. A detailed discussion of the contraceptive options for patients with chronic liver disease, in general, and Wilson's disease, in particular, follows the case report.

Original languageEnglish
Pages (from-to)241-244
Number of pages4
Issue number4
StatePublished - 1 Oct 1997
Externally publishedYes


  • Contraception
  • Liver disease
  • Portal hypertension
  • Pregnancy
  • Wilson's disease

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology


Dive into the research topics of 'The contraceptive choice for a Wilson's disease patient with chronic liver disease'. Together they form a unique fingerprint.

Cite this